These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34503167)

  • 41. Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM.
    Liu B; Ji Q; Cheng Y; Liu M; Zhang B; Mei Q; Liu D; Zhou S
    J Nanobiotechnology; 2022 Mar; 20(1):161. PubMed ID: 35351131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 43. PD-L1 Inhibitor Regulates the miR-33a-5p/PTEN Signaling Pathway and Can Be Targeted to Sensitize Glioblastomas to Radiation.
    Xia W; Zhu J; Tang Y; Wang X; Wei X; Zheng X; Hou M; Li S
    Front Oncol; 2020; 10():821. PubMed ID: 32537433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcome.
    Miyazaki T; Ishikawa E; Matsuda M; Akutsu H; Osuka S; Sakamoto N; Takano S; Yamamoto T; Tsuboi K; Matsumura A
    J Neurooncol; 2017 Jun; 133(2):277-285. PubMed ID: 28447277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment.
    Hardcastle J; Mills L; Malo CS; Jin F; Kurokawa C; Geekiyanage H; Schroeder M; Sarkaria J; Johnson AJ; Galanis E
    Neuro Oncol; 2017 Apr; 19(4):493-502. PubMed ID: 27663389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application prospect of peptide-modified nano targeting drug delivery system combined with PD-1/PD-L1 based immune checkpoint blockade in glioblastoma.
    Song P; Zhao X; Xiao S
    Int J Pharm; 2020 Nov; 589():119865. PubMed ID: 32919004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis.
    Marisetty AL; Lu L; Veo BL; Liu B; Coarfa C; Kamal MM; Kassem DH; Irshad K; Lu Y; Gumin J; Henry V; Paulucci-Holthauzen A; Rao G; Baladandayuthapani V; Lang FF; Fuller GN; Majumder S
    Neuro Oncol; 2019 Jun; 21(6):775-785. PubMed ID: 30953587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Downregulation of PD-L1 via FKBP5 by celecoxib augments antitumor effects of PD-1 blockade in a malignant glioma model.
    Yamaguchi I; Nakajima K; Shono K; Mizobuchi Y; Fujihara T; Shikata E; Yamaguchi T; Kitazato K; Sampetrean O; Saya H; Takagi Y
    Neurooncol Adv; 2020; 2(1):vdz058. PubMed ID: 32642723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes.
    Gabrusiewicz K; Li X; Wei J; Hashimoto Y; Marisetty AL; Ott M; Wang F; Hawke D; Yu J; Healy LM; Hossain A; Akers JC; Maiti SN; Yamashita S; Shimizu Y; Dunner K; Zal MA; Burks JK; Gumin J; Nwajei F; Rezavanian A; Zhou S; Rao G; Sawaya R; Fuller GN; Huse JT; Antel JP; Li S; Cooper L; Sulman EP; Chen C; Geula C; Kalluri R; Zal T; Heimberger AB
    Oncoimmunology; 2018; 7(4):e1412909. PubMed ID: 29632728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PD-L1 Expression Fluctuates Concurrently with Cyclin D in Glioblastoma Cells.
    Tufano M; D'Arrigo P; D'Agostino M; Giordano C; Marrone L; Cesaro E; Romano MF; Romano S
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hybrids by tumor-associated macrophages × glioblastoma cells entail nuclear reprogramming and glioblastoma invasion.
    Cao MF; Chen L; Dang WQ; Zhang XC; Zhang X; Shi Y; Yao XH; Li Q; Zhu J; Lin Y; Liu S; Chen Q; Cui YH; Zhang X; Bian XW
    Cancer Lett; 2019 Feb; 442():445-452. PubMed ID: 30472185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Musashi-1 Regulates MIF1-Mediated M2 Macrophage Polarization in Promoting Glioblastoma Progression.
    Yang YP; Chien CS; Yarmishyn AA; Chan MS; Lee AC; Chen YW; Huang PI; Ma HI; Lo WL; Chien Y; Lin WC; Wang ML; Chen MT
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33918794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer progression.
    Zheng NN; Zhou M; Sun F; Huai MX; Zhang Y; Qu CY; Shen F; Xu LM
    World J Gastroenterol; 2020 Jul; 26(26):3737-3749. PubMed ID: 32774054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prognostic Analysis of NSCLC Based on the Tumor-associated Macrophages, Tumor Neo-vessels and PD-L1 Expression in Tumor Microenvironment].
    Hang Q; Ying H; Cheng G; Yang S; Jin J; Chen Y; Chen Q; Jiang Y; Zhao Q; Fang M; Chen M; Lai X
    Zhongguo Fei Ai Za Zhi; 2020 Oct; 23(10):837-844. PubMed ID: 33070512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immune Checkpoint Inhibition Followed by Tumor Infiltration of Dendritic Cells in Murine Neuro-2a Neuroblastoma.
    Inoue S; Horiuchi Y; Setoyama Y; Takeuchi Y; Beck Y; Murakami T; Odaka A
    J Surg Res; 2020 Sep; 253():201-213. PubMed ID: 32380346
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myeloid-Derived Suppressive Cells Promote B cell-Mediated Immunosuppression via Transfer of PD-L1 in Glioblastoma.
    Lee-Chang C; Rashidi A; Miska J; Zhang P; Pituch KC; Hou D; Xiao T; Fischietti M; Kang SJ; Appin CL; Horbinski C; Platanias LC; Lopez-Rosas A; Han Y; Balyasnikova IV; Lesniak MS
    Cancer Immunol Res; 2019 Dec; 7(12):1928-1943. PubMed ID: 31530559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exosomal L1CAM Stimulates Glioblastoma Cell Motility, Proliferation, and Invasiveness.
    Pace KR; Dutt R; Galileo DS
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors.
    Chen D; Li G; Ji C; Lu Q; Qi Y; Tang C; Xiong J; Hu J; Yasar FBA; Zhang Y; Hoon DSB; Yao Y; Zhou L
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457124
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment.
    van den Bossche WBL; Kleijn A; Teunissen CE; Voerman JSA; Teodosio C; Noske DP; van Dongen JJM; Dirven CMF; Lamfers MLM
    Neuro Oncol; 2018 Oct; 20(11):1494-1504. PubMed ID: 29796615
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neddylation inhibition upregulates PD-L1 expression and enhances the efficacy of immune checkpoint blockade in glioblastoma.
    Zhou S; Zhao X; Yang Z; Yang R; Chen C; Zhao K; Wang W; Ma Y; Zhang Q; Wang X
    Int J Cancer; 2019 Aug; 145(3):763-774. PubMed ID: 31044422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.